Literature DB >> 2712803

Modulation of human plasma fibronectin levels following exercise.

D A DuBose1, L E Armstrong, W J Kraemer, M Lukason.   

Abstract

Elevated reticuloendothelial function and plasma fibronectin (PF) level correlate with reduced rat heat shock mortality. Procedures that enhance human PF level may offer some advantage in dealing with the adverse effects of environmental stress. Both short- (STE) and long- (LTE) term exercise programs were evaluated for their ability to increase male human PF. STE (1 week; N = 14) consisted of treadmill running (0% grade) in a hot environment (41 degrees C, 39% relative humidity). The LTE (12 weeks) program was studied in two parts (LTE-1, N = 10; LTE-2, N = 19), with each part divided into four subject groups. Two groups performed the same running program combined with either full-body or upper-body weight training. The other two groups participated in only the running or full-body weight training. STE and LTE-2 had a significantly (p less than 0.05) higher mean initial PF level than LTE-1. STE (337.1 +/- 22.8 vs. 372.5 +/- 17.0 micrograms.ml-1). LTE-1 (266.0 +/- 13.0 vs. 348.0 +/- 18.8 micrograms.ml-1), and LTE-2 (370.9 +/- 13.8 vs. 413.6 +/- 12.5 micrograms.ml-1) all resulted in significant (p less than 0.05) increases in PF after program completion. Therefore, with diverse exercise training programs, PF elevations were attained even when initial concentration was high or the program was of short or long duration. However, PF level was suppressed in LTE-2 at 4 (323.2 +/- 10.8 micrograms.ml(-1)) and 8 (339.6 +/- 15.0 micrograms.ml(-1)) weeks before elevations occurred at 12 weeks.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712803

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  1 in total

1.  Cellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes.

Authors:  Ahmad H Alghadir; Sami A Gabr; Einas Al-Eisa
Journal:  J Phys Ther Sci       Date:  2016-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.